Weight loss drugs linked to loss of hair in major new study
A new study involving 50,000 participants suggests a link between GLP-1 agonist weight loss drugs like Wegovy, Ozempic, and Mounjaro and an increased risk of hair loss. Regulatory bodies in the US and UK have received hundreds of reports from patients experiencing alopecia while using these medications.
Why it matters
As the popularity of weight-loss drugs surges, identifying potential side effects is critical for patient safety and informed medical decision-making.
The study looked at 50,000 people on GLP-1 agonist drugs such as Wegovy and Mounjaro
Bookmark Comments Go to comments Bookmark popover Removed from bookmarks
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in